Foxp3+ Regulatory T Cells Are Required for Recovery from Severe Sepsis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Kühlhorn, Franziska ^a   Rath, Matthias ^a   Schmoeckel, Katrin ^a   Cziupka, Katharina ^a   Nguyen, Huu Hung ^a   Hildebrandt, Petra ^b   Hünig, Thomas ^c   Sparwasser, Tim ^d   Huehn, Jochen ^e   Pötschke, Christian ^a   Bröker, Barbara M ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CD4 LYMPHOCYTE PERCENTAGE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MOUSE; NEUTROPHIL COUNT; NONHUMAN; REGULATORY T LYMPHOCYTE; SEPSIS; SURVIVAL TIME; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; CECUM; CELL MOVEMENT; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; LIGATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; PERITONEUM; PUNCTURES; SEPSIS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, REGULATORY;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS;

EID: 84878407792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065109     Document Type: Article

References (79)

1. Slade E, Tamber PS, Vincent JL, (2003) The Surviving Sepsis Campaign: raising awareness to reduce mortality. Crit Care 7: 1-2.
2. Marshall JC, (2004) Intra-abdominal infections. Microbes Infect 6: 1015-1025.
3. Busse M, Traeger T, Potschke C, Billing A, Dummer A, et al. (2008) Detrimental role for CD4+ T lymphocytes in murine diffuse peritonitis due to inhibition of local bacterial elimination. Gut 57: 188-195.
4. Martignoni A, Tschop J, Goetzman HS, Choi LG, Reid MD, et al. (2008) CD4-expressing cells are early mediators of the innate immune system during sepsis. Shock 29: 591-597.
5. Reim D, Westenfelder K, Kaiser-Moore S, Schlautkotter S, Holzmann B, et al. (2009) Role of T cells for cytokine production and outcome in a model of acute septic peritonitis. Shock 31: 245-250.
6. Stromberg PE, Woolsey CA, Clark AT, Clark JA, Turnbull IR, et al. (2009) CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. Faseb J 23: 1817-1825.
7. Xiao H, Siddiqui J, Remick DG, (2006) Mechanisms of mortality in early and late sepsis. Infect Immun 74: 5227-5235.
8. Kim KD, Zhao J, Auh S, Yang X, Du P, et al. (2007) Adaptive immune cells temper initial innate responses. Nat Med 13: 1248-1252.
9. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204: 57-63.
10. Wollenberg I, Agua-Doce A, Hernandez A, Almeida C, Oliveira VG, et al. (2011) Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J Immunol 187: 4553-4560.
11. Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, et al. (2004) The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172: 3157-3166.
12. Singh KP, Gerard HC, Hudson AP, Reddy TR, Boros DL, (2005) Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology 114: 410-417.
13. Demengeot J, Zelenay S, Moraes-Fontes MF, Caramalho I, Coutinho A, (2006) Regulatory T cells in microbial infection. Springer Semin Immunopathol 28: 41-50.
14. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
15. Belkaid Y, Rouse BT, (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6: 353-360.
16. Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L, et al. (2008) Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J Immunol 180: 2496-2503.
17. Belkaid Y, Tarbell K, (2009) Regulatory T cells in the control of host-microorganism interactions (*). Annu Rev Immunol 27: 551-589.
18. Heuer JG, Zhang T, Zhao J, Ding C, Cramer M, et al. (2005) Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol 174: 7141-7146.
19. Scumpia PO, Delano MJ, Kelly KM, O′Malley KA, Efron PA, et al. (2006) Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 177: 7943-7949.
20. Wisnoski N, Chung CS, Chen Y, Huang X, Ayala A, (2007) The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 27: 251-257.
21. Chen X, Baumel M, Mannel DN, Howard OM, Oppenheim JJ, (2007) Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol 179: 154-161.
22. Stephens LA, Mason D, (2000) CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. J Immunol 165: 3105-3110.
23. Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci U S A 99: 13031-13036.
24. Leithauser F, Meinhardt-Krajina T, Fink K, Wotschke B, Moller P, et al. (2006) Foxp3-expressing CD103+ regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis. Am J Pathol 168: 1898-1909.
25. Couper KN, Blount DG, de Souza JB, Suffia I, Belkaid Y, et al. (2007) Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J Immunol 178: 4136-4146.
26. Lahl K, Sparwasser T, (2011) In vivo depletion of FoxP3+ Tregs using the DEREG mouse model. Methods Mol Biol 707: 157-172.
27. Venet F, Chung CS, Monneret G, Huang X, Horner B, et al. (2008) Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 83: 523-535.
28. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
29. Khattri R, Cox T, Yasayko SA, Ramsdell F, (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337-342.
30. Zheng Y, Rudensky AY, (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8: 457-462.
31. Liston A, Farr AG, Chen Z, Benoist C, Mathis D, et al. (2007) Lack of Foxp3 function and expression in the thymic epithelium. J Exp Med 204: 475-480.
32. Kim J, Lahl K, Hori S, Loddenkemper C, Chaudhry A, et al. (2009) Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol 183: 7631-7634.
33. Put S, Avau A, Humblet-Baron S, Schurgers E, Liston A, et al. (2012) Macrophages have no lineage history of Foxp3 expression. Blood 119: 1316-1318.
34. Hahn BH, Singh RP, La Cava A, Ebling FM, (2005) Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors. J Immunol 175: 7728-7737.
35. Tsai YG, Yang KD, Niu DM, Chien JW, Lin CY, (2010) TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy. J Immunol 184: 7229-7237.
36. Nakagawa T, Tsuruoka M, Ogura H, Okuyama Y, Arima Y, et al. (2010) IL-6 positively regulates Foxp3+CD8+ T cells in vivo. Int Immunol 22: 129-139.
37. Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB, et al. (2012) CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. J Immunol 189: 464-474.
38. Sawamukai N, Satake A, Schmidt AM, Lamborn IT, Ojha P, et al. (2012) Cell-autonomous role of TGFbeta and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD. Blood 119: 5575-5583.
39. Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, et al. (2007) CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res 13: 6947-6958.
40. Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, et al. (2009) Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58: 520-529.
41. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA, (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4: 31-36.
42. Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, et al. (1998) Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 66: 2300-2309.
43. Gogishvili T, Langenhorst D, Luhder F, Elias F, Elflein K, et al. (2009) Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. PLoS One 4: e4643.
44. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, et al. (2004) Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med 32: 2329-2331.
45. Saito K, Wagatsuma T, Toyama H, Ejima Y, Hoshi K, et al. (2008) Sepsis is characterized by the increases in percentages of circulating CD4+CD25+ regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med 216: 61-68.
46. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, et al. (2009) Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35: 678-686.
47. Cavassani KA, Carson WFt, Moreira AP, Wen H, Schaller MA, et al. (2010) The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood 115: 4403-4411.
48. Zeng M, Guinet E, Nouri-Shirazi M, (2009) Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation. Transpl Immunol 22: 82-92.
49. Nicolson KS, O′Neill EJ, Sundstedt A, Streeter HB, Minaee S, et al. (2006) Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function. J Immunol 176: 5329-5337.
50. Suvas S, Rouse BT, (2006) Treg control of antimicrobial T cell responses. Curr Opin Immunol 18: 344-348.
51. Mayer CT, Floess S, Baru AM, Lahl K, Huehn J, et al. (2011) CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity. Eur J Immunol 41: 716-725.
52. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, et al. (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169: 569-576.
53. Hotchkiss RS, Chang KC, Grayson MH, Tinsley KW, Dunne BS, et al. (2003) Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci U S A 100: 6724-6729.
54. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, et al. (2003) Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 31: 2068-2071.
55. Banz A, Pontoux C, Papiernik M, (2002) Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J Immunol 169: 750-757.
56. Chen X, Murakami T, Oppenheim JJ, Howard OM, (2004) Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol 34: 859-869.
57. Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, et al. (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13: 1299-1307.
58. Taylor SR, Alexander DR, Cooper JC, Higgins CF, Elliott JI, (2007) Regulatory T cells are resistant to apoptosis via TCR but not P2X7. J Immunol 178: 3474-3482.
59. Chen W, Konkel JE, (2010) TGF-beta and 'adaptive' Foxp3(+) regulatory T cells. J Mol Cell Biol 2: 30-36.
60. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, et al. (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172: 5149-5153.
61. Selvaraj RK, Geiger TL (2007) A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol 179: 11 p following 1390.
62. van Amelsfort JM, van Roon JA, Noordegraaf M, Jacobs KM, Bijlsma JW, et al. (2007) Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 56: 732-742.
63. Liu G, Zhao Y, (2007) Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 122: 149-156.
64. van Maren WW, Jacobs JF, de Vries IJ, Nierkens S, Adema GJ, (2008) Toll-like receptor signalling on Tregs: to suppress or not to suppress? Immunology 124: 445-452.
65. Dai J, Liu B, Li Z, (2009) Regulatory T cells and Toll-like receptors: what is the missing link? Int Immunopharmacol 9: 528-533.
66. Liu H, Komai-Koma M, Xu D, Liew FY, (2006) Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A 103: 7048-7053.
67. Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, et al. (2006) Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116: 485-494.
68. Pasare C, Medzhitov R, (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
69. Wraith DC, Nicolson KS, Whitley NT, (2004) Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol 16: 695-701.
70. Inoue S, Bo L, Bian J, Unsinger J, Chang K, et al. (2011) Dose-dependent effect of anti-CTLA-4 on survival in sepsis. Shock 36: 38-44.
71. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, et al. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13: 423-431.
72. Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, et al. (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29: 303-309.
73. Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, et al. (2007) Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Diabetes 56: 2116-2123.
74. Walker LS, (2009) Regulatory T cells overturned: the effectors fight back. Immunology 126: 466-474.
75. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, et al. (2003) CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197: 111-119.
76. Lewkowicz P, Lewkowicz N, Sasiak A, Tchorzewski H, (2006) Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol 177: 7155-7163.
77. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, et al. (2007) CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 104: 19446-19451.
78. Tang Q, Bluestone JA, (2008) The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9: 239-244.
79. Shevach EM, (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.